Two world-class pharmaceutical companies announced an agreement for a potential first-in-class vaccine against extraintestinal pathogenic E. coli. On October 3, 2023, France-based Sanofi confirmed it has agreed with Janssen Pharmaceuticals, Inc., a Johnson & Johnson company,... READ →
Precision Vaccinations
/ October 4th, 2023Eliminating fake vaccine news with pharmacist, nurse, and physician review.
For more articles, try our search.